Grace Halsey

MOBILE study lead author Tom Martens, MD, talks about the inherent benefits of CGM for T2D patients on basal insulin treated in primary care and also the challenges to this vision of patient care.

MOBILE study lead author Thomas W. Martens, MD, discusses results of the study which was designed to capture CGM results in real-world primary care practice.

The CDC has intensified surveillance of the Delta variant of SARS-CoV-2 which now accounts for 10% of new US COVID-19 infections.

Patients with T2D see significant improvement in glycemic control using continuous glucose monitoring. MOBILE study lead author Thomas W. Martens, MD, highlights the evidence.

A new study found that patients with severe obesity who had even one discussion about bariatric surgery with a clinician were more likely to lose weight but that the discussions are infrequent.

A new study challenges traditional criteria for patient selection for metabolic surgery, demonstrating significant weight loss and disease remission for those with BMI of 30-35.

The vaccine is indicated for prevention of invasive disease and pneumonia caused by 20 Streptococcus pneumoniae serotypes.

Analysis of NHANES data shows significant downturns in control of the 3 risk factors in patients with diabetes, which could mean population-level increases in related illness.

Poll: 91% of women don’t know heart disease is the #1 cause of death in women and 81% aren’t aware that the Pap test screens only for cervical cancer. Counseling and education are needed.

An Australian study of more than 7000 adults suggests 2 servings of whole fruit per day helps preserve insulin sensitivity and mitigate risk for type 2 diabetes.

The FDA approved today the first drug that targets the pathophysiolgic process responsible for Alzheimer disease and the first drug since 2003 to be approved for any Alzheimer treatment.

Semaglutide 2.4 mg is the first drug approved for chronic weight management since 2014 and the first once-weekly GLP-1 receptor agonist to be approved for that purpose.

MOBILE study group: in patients with type 2 diabetes on a less intensive insulin regimen, CGM use lowered A1c and increased time in target glucose range vs traditional blood glucose monitoring.

A new study reveals that nearly three-quarters of medication organizer packages contain a drug class from which a single pill could be lethal for a child.

Magnet technology in the iPhone 12 Pro Max that allows the device to charge wirelessly can significantly impair function of a variety of cardiac implantable electronic devices.

In people without diabetes and considered low risk for CVD, A1c was associated in a graded, positive fashion with subclinical atherosclerosis, even at prediabetes levels.

The landmark Diabetes Prevention Program (DPP) trial and follow-up studies proved that risk of T2D can be reduced in patients at high risk for the disease. Do you know by how much?

Four major cardiology organizations stand behind increased government action to eradicate tobacco use worldwide. Click here for a summary of why, why now, and how.

Adults with OCD were more than 3 times as likely to have an ischemic stroke after age 40 than those without the disorder, according to a study published in Stroke.

For patients with moderate-to-severe persistent asthma, new guidelines from the NAEPP recommend SMART, particularly for patients with a recent disease exacerbation.

UK investigators found guideline-recommended post-specialist care deficient, including low levels of nutrition monitoring and widely variable prescription of dietary supplements.

Results of this large study also suggest women with high pericardial fat volume are at greater risk for HF than men, findings that have implications for stratifying prevention and treatment.

Truth: 67% of US unvaccinated adults believe or cannot judge the veracity of the 5 myths that follow. With more than half the population not fully vaccinated, there is more work to do.

An analysis of final data from the landmark SPRINT trial has confirmed findings that support aggressive treatment of hypertension to reduce CV morbidity and mortality.

In the phase 2/3 TeenCOVE study, Moderna's mRNA-1273 demonstrated immunogenicity noninferior to that seen in the phase 3 adult study comparator group.

The CDC defines SARS-CoV-2 variants as of interest, of concern, and of high consequence. Get a quick update on how knowledge of known variants is changing.

Maine continues to lead the country in percentage of population fully vaccinated at 51.82%, according to CDC data. Mississippi has shifted into the 51st spot.

New topline data from the global SURPASS-4 trial shows treatment with investigational agent tirzepatide led to superior reductions in A1c and body weight vs insulin glargine.

ACC.2021: A new analysis of FIDELIO-DKD found patients with chronic kidney disease and type 2 diabetes were about 30% less likely to develop atrial fibrillation vs those treated with placebo.

Most 2021 final-year medical residents want to work in hospital settings, none want to work in rural areas, and male residents expect to earn more than $250 000 in their first practice.